James Hambro & Partners LLP Cuts Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

James Hambro & Partners LLP reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.9% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 242,622 shares of the medical equipment provider’s stock after selling 2,187 shares during the period. Intuitive Surgical comprises 5.0% of James Hambro & Partners LLP’s holdings, making the stock its 7th largest position. James Hambro & Partners LLP’s holdings in Intuitive Surgical were worth $126,664,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of ISRG. Mount Yale Investment Advisors LLC raised its holdings in Intuitive Surgical by 5.7% in the fourth quarter. Mount Yale Investment Advisors LLC now owns 484 shares of the medical equipment provider’s stock worth $253,000 after purchasing an additional 26 shares in the last quarter. Webster Bank N. A. grew its position in shares of Intuitive Surgical by 22.4% in the 4th quarter. Webster Bank N. A. now owns 393 shares of the medical equipment provider’s stock worth $205,000 after buying an additional 72 shares during the period. Pacer Advisors Inc. increased its stake in shares of Intuitive Surgical by 3.6% in the 4th quarter. Pacer Advisors Inc. now owns 46,034 shares of the medical equipment provider’s stock worth $24,028,000 after acquiring an additional 1,620 shares in the last quarter. United Asset Strategies Inc. lifted its position in Intuitive Surgical by 1.1% during the 4th quarter. United Asset Strategies Inc. now owns 2,408 shares of the medical equipment provider’s stock valued at $1,257,000 after acquiring an additional 27 shares during the period. Finally, Cornerstone Wealth Group LLC boosted its stake in Intuitive Surgical by 0.3% during the fourth quarter. Cornerstone Wealth Group LLC now owns 12,854 shares of the medical equipment provider’s stock worth $6,709,000 after acquiring an additional 33 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Activity at Intuitive Surgical

In related news, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the sale, the insider now directly owns 8,757 shares in the company, valued at approximately $4,597,425. The trade was a 72.34 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 42,453 shares of company stock worth $22,059,506. 0.90% of the stock is owned by insiders.

Intuitive Surgical Trading Down 4.0 %

Shares of ISRG opened at $584.05 on Monday. The firm has a fifty day simple moving average of $547.16 and a two-hundred day simple moving average of $505.21. The firm has a market cap of $208.03 billion, a PE ratio of 93.90, a P/E/G ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Analysts Set New Price Targets

ISRG has been the subject of a number of analyst reports. Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. BTIG Research boosted their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Truist Financial raised their price target on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday. Finally, Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $583.83.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.